- Key Insight: The real reason health costs are rising is a structural shift driven by GLP-1s.
- What’s at Stake: Employers face long-term affordability crises as millions of workers become eligible for expensive treatments.
- Supporting Data: 18.3% rise in prescription drug costs for certain employer-sponsored health plans.
- Source: Bullets generated by AI with editorial review
The growing popularity of expensive GLP-1 drugs is helping push employer-sponsored health plan costs to their fastest growth rate in 15 years for 2027, according to a new survey.
